ByrneWallace advised Neuromod Devices in connection with an €8 million fundraising...
ByrneWallace advise Nuvo Pharmaceuticals (Ireland) DAC (Nuvo Ireland) in relation to its acquisition..
ByrneWallace advise Inflazome Limited in relation to its €40 million Series B Financing to develop..
ByrneWallace advised Phibro Animal Health Corporation, a NASDAQ listed global diverse animal health ..
ByrneWallace advised Irish-listed pharmaceutical company Amryt Pharma PLC on an exclusive in-licence..
Acted for Inflazome Limited in connection with its recent Series A financing round for up to €15 m..
We use strictly necessary cookies to enable you to move around our website and use its features. You may disable these by changing your browser settings, but this may affect how our website functions.
We would also like to set optional analytics cookies to help us improve our website by collecting and reporting information on how you use it. However, we will not set these cookies unless you enable them by using the on/off tool below and click the save and close button. Using this tool will set a cookie on your device to remember your preferences.
For more detailed information about the cookies we use, see our Privacy and Cookies Policy.